Leukemia
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Pediatric ALL: Etiology, Diagnosis and Management
FEATURING
ÖZlem TüFekçI GüRocak
- 12 views
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CML Case Discussion: Elderly Patients not Meeting ELN Milestones
FEATURING
Mohamed Isam Sharif
- 6 views
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CLL Case: Acquired Del(17p) at Relapse
FEATURING
Melis Dila Özer Çerme
- 2 views
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
ALL Case: B-ALL Arising During Len Maintenance in Myeloma Patient
FEATURING
Kubra Ozsoy
- 1 view
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Novel Agents in the Treatment of R/R CLL
FEATURING
Nitin Jain
- 34 views
- October 9, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Targeted Therapies in AML With a Focus on FLT3 Inhibitors
FEATURING
Naval Daver
- 26 views
- October 8, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in CLL: Continuous or Finite Duration Therapy
FEATURING
Nitin Jain
- 116 views
- October 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Ph+ ALL Management: Case-Based Discussion
FEATURING
Kivanc Koruk
- 11 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
AML Case Discussion: FLT3-ITD+ High-Risk Disease
FEATURING
Fehmi Hindilerden
- 17 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Immunotherapy and Sequencing CD19-Targeted Therapies in Adults With R/R ALL
FEATURING
Elias Jabbour
- 37 views
- September 27, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
How I Treat R/R CML in 2024: Strategies and Emerging Therapies
FEATURING
Elias Jabbour
- 17 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
TKI Discontinuation in CML: Defining Eligibility Criteria and Predictors of Success
FEATURING
Mohamed A. Yassin
- 22 views
- September 25, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
A Case of CMML With Recurrent Skin Involvement
FEATURING
Eren Arslan Davulcu
- 11 views
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Critical Re-Evaluation of Established Practices in CML Management
FEATURING
Hagop Kantarjian
- 138 views
- September 16, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of R/R AML: Treatment Options and Case Insights
FEATURING
Valentina Bonuomo
- 37 views
- September 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 7+3 Is No Longer the Standard of Care
FEATURING
Tapan Kadia
- 557 views
- September 11, 2024
- 5
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Approach to MRD Monitoring in AML: Assessing Treatment Efficacy and Relapse Risk
FEATURING
Tapan Kadia
- 89 views
- September 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Should Be Used Upfront in Adult Patients
FEATURING
Dieter Hoelzer
- 27 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Is Not Necessary Upfront in Adult Patients
FEATURING
Elias Jabbour
- 35 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CLL Case Discussion: First Line Treatment Strategies
FEATURING
Damla Ortaboz
- 49 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Incorporation of Targeted and Immunotherapies in ALL
FEATURING
Hagop Kantarjian
- 181 views
- August 30, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CAR-T in R/R ALL: Case-Based Discussion of Lymphodepletion and Toxicity Management
FEATURING
Ebru Erdogan
- 11 views
- August 30, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
The Importance of MRD in ALL
FEATURING
Farhad Ravandi
- 137 views
- August 29, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of AML in Older Patients
FEATURING
Farhad Ravandi
- 192 views
- August 29, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Approaches to Managing T-Cell ALL
FEATURING
Ahmad Ibrahim
- 19 views
- August 28, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
TKI Toxicity Management in CML: A Case-Based Discussion
FEATURING
Awni Alshurafa
- 19 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of Persistently MRD+ ALL
FEATURING
Asli Odabasi Giden
- 27 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 3+7 is the SOC Induction Therapy for AML
FEATURING
Ant Uzay
- 50 views
- August 15, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Venetoclax + Ibrutinib as 1L Treatment in Patients With CLL: Meta-Analysis of RCTs
FEATURING
Ahmet Sarici
- 24 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Options for Finite-Duration Therapy With BTKis in CLL
FEATURING
Ahmad Ibrahim
- 148 views
- August 13, 2024